“I like the pricing environment a lot and we have a lot of capacity to work with to do a cash transaction of meaningful size — and it would be transformative,” Mr. DeVeydt said, according to the report.
Mr. DeVeydt’s comments follow last week’s analyst speculation that Aetna could acquire Cigna or Humana, which reignited past talks of an acquisition among the Big Five.
Low interest rates are creating good conditions for an acquisition, Mr. DeVeydt said, and the company is considering expanding business in Florida, Texas and California. Anthem’s first focus will be targeting those markets, he said, and then it will work on growing Medicare. He also told investors acquisitions are not necessary for Anthem to grow business in New York, Ohio and California, according to the report.
More articles on payer issues:
Up to 17M women could lose mammogram coverage
HHS says insurers required to cover all contraceptives: 3 things to know
WellCare posts better-than-expected profit
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
